Not applicableStudy completedNCT03280303What this trial is testingPalbociclib in Real World PracticeWho this might be right forAdvanced Breast CancerMetastatic Breast Cancer Pfizer 1,285
Not applicableUnknownNCT03881501What this trial is testingEvaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Huazhong University of Science and Technology 2
Early research (Phase 1)UnknownNCT05555212What this trial is testingTo Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR MutationWho this might be right forNon-small Cell Lung Cancer Qilu Pharmaceutical Co., Ltd. 72
Not applicableStudy completedNCT04887519What this trial is testingBrigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase Takeda 39
Testing effectiveness (Phase 2)Looking for participantsNCT06970119What this trial is testingA Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate CancerWho this might be right forProstate Cancer Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07710612What this trial is testingABSK043 Combined With OsimertinibWho this might be right forNon-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive Abbisko Therapeutics Co, Ltd 72
Testing effectiveness (Phase 2)Study completedNCT00081107What this trial is testingEpothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06114511What this trial is testingBL-M07D1 in Patients With HER2-Overexpressing or HER2-Mutant Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT01750281What this trial is testingAssess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.Who this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV AstraZeneca 212
Early research (Phase 1)Study completedNCT01124630What this trial is testingStudy of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other TreatmentsWho this might be right forMetastatic Colorectal Cancer Daiichi Sankyo 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808567What this trial is testingEvaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma.Who this might be right forPancreatic Adenocarcinoma ResectableNon MetastaticECOG Performance Status Score of 0 or 1 Gustave Roussy, Cancer Campus, Grand Paris 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05853575What this trial is testingTrial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplasm of Lung Mirati Therapeutics Inc. 200
Large-scale testing (Phase 3)Study completedNCT03515837What this trial is testingStudy of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)Who this might be right forNon-small Cell Lung Cancer Merck Sharp & Dohme LLC 492
Not applicableEnded earlyNCT02671045What this trial is testingGenomic Profiling in Previously Untreated Metastatic Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-small Cell Lung Cota Inc. 649
Testing effectiveness (Phase 2)Ended earlyNCT00783471What this trial is testingDocetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)Who this might be right forAdvanced Non-Small Cell Lung Cancer Hellenic Cooperative Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT04647344What this trial is testingAK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Non-Small Cell Stage IIIB/IIIC/IV Akeso 46
Not applicableApproved For MarketingNCT04829422What this trial is testingEarly Access Program of Lazertinib in Republic of KoreaWho this might be right forLung Cancer Yuhan Corporation
Not applicableUnknownNCT01877902What this trial is testingStudy Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health SystemWho this might be right forCarcinoma, Non-Small-Cell Lung Fundación Pública Andaluza Progreso y Salud 190
Testing effectiveness (Phase 2)Study completedNCT03464201What this trial is testingEnzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III StudyWho this might be right forOvarian Cancer Grupo Español de Tumores Huérfanos e Infrecuentes 16
Not applicableLooking for participantsNCT06952101What this trial is testingA Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and MininvasivityWho this might be right forRectal AdenocarcinomaNon Metastatic Fondazione del Piemonte per l'Oncologia 200